Suppr超能文献

5至11岁儿童哮喘的门诊管理:实践指南

Outpatient management of asthma in children age 5-11 years: guidelines for practice.

作者信息

Watts Barbara

机构信息

Tri-County Internal Medicine, 807 Jackson Trace Road, Wetumpka, AL 36092, USA.

出版信息

J Am Acad Nurse Pract. 2009 May;21(5):261-9. doi: 10.1111/j.1745-7599.2009.00403.x.

Abstract

PURPOSE

To increase awareness among nurse practitioners (NPs) regarding diagnostic and treatment guidelines for asthma for the 5-11 year age group recently updated by the National Asthma Education Prevention Program-Expert Panel 3 (NAEPP-EPR3).

DATA SOURCES

NAEPP-EPR3 guidelines for the diagnosis and management of asthma released from the National Heart, Lung, and Blood Institute in August 2007, selected clinical trials, meta-analyses, and clinical reviews.

CONCLUSIONS

Recent research has revealed that children suffering from asthma in the United States are underdiagnosed and their asthma is poorly controlled. Compelling evidence supports that children classified as having persistent asthma following NAEPP-EPR3 guidelines benefit from daily inhaled corticosteroid therapy, yet many are misclassified and undertreated.

IMPLICATIONS FOR PRACTICE

With application of current guidelines from NAEPP-EPR3, NPs can more effectively assess, diagnose, treat, and foster a collaborative self-management plan for children age 5-11 years. These interventions will result in an improved quality of life and decreased health risks for this young population.

摘要

目的

提高执业护士对国家哮喘教育与预防计划专家小组3(NAEPP-EPR3)最近更新的5至11岁年龄组哮喘诊断和治疗指南的认识。

数据来源

2007年8月美国国立心肺血液研究所发布的NAEPP-EPR3哮喘诊断和管理指南、选定的临床试验、荟萃分析和临床综述。

结论

最近的研究表明,美国患有哮喘的儿童诊断不足且哮喘控制不佳。有力证据支持,按照NAEPP-EPR3指南被归类为持续性哮喘的儿童可从每日吸入糖皮质激素治疗中获益,但许多儿童被错误分类且治疗不足。

对实践的启示

通过应用NAEPP-EPR3的现行指南,执业护士可以更有效地评估、诊断、治疗5至11岁儿童,并促进制定协作性自我管理计划。这些干预措施将改善这一年轻人群的生活质量并降低健康风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验